Synthesis and Biological Evaluation of RGD–Cryptophycin Conjugates for Targeted Drug Delivery
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Synthesis and Biological Evaluation of RGD–Cryptophycin Conjugates for Targeted Drug Delivery
Authors
Keywords
-
Journal
Pharmaceutics
Volume 11, Issue 4, Pages 151
Publisher
MDPI AG
Online
2019-04-02
DOI
10.3390/pharmaceutics11040151
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Novel unit B cryptophycin analogues as payloads for targeted therapy
- (2018) Eduard Figueras et al. Beilstein Journal of Organic Chemistry
- On the design principles of peptide–drug conjugates for targeted drug delivery to the malignant tumor site
- (2018) Eirinaios I Vrettos et al. Beilstein Journal of Organic Chemistry
- Synthesis and biological evaluation of RGD and isoDGR peptidomimetic-α-amanitin conjugates for tumor-targeting
- (2018) Lizeth Bodero et al. Beilstein Journal of Organic Chemistry
- Modulating Antibody–Drug Conjugate Payload Metabolism by Conjugation Site and Linker Modification
- (2018) Dian Su et al. BIOCONJUGATE CHEMISTRY
- FRET Reagent Reveals the Intracellular Processing of Peptide-Linked Antibody–Drug Conjugates
- (2018) Byoung-Chul Lee et al. BIOCONJUGATE CHEMISTRY
- Cancer-targeted delivery systems based on peptides
- (2018) Theodora Chatzisideri et al. Future Medicinal Chemistry
- Peptide-based targeted therapeutics: Focus on cancer treatment
- (2018) Fatemeh Araste et al. JOURNAL OF CONTROLLED RELEASE
- RGD-mediated delivery of small-molecule drugs
- (2017) Sotirios Katsamakas et al. Future Medicinal Chemistry
- Linker stability influences the anti-tumor activity of acetazolamide-drug conjugates for the therapy of renal cell carcinoma
- (2017) Samuele Cazzamalli et al. JOURNAL OF CONTROLLED RELEASE
- Cryptophycins: cytotoxic cyclodepsipeptides with potential for tumor targeting
- (2017) Christine Weiss et al. JOURNAL OF PEPTIDE SCIENCE
- Strategies and challenges for the next generation of antibody–drug conjugates
- (2017) Alain Beck et al. NATURE REVIEWS DRUG DISCOVERY
- Exploring the Role of RGD-Recognizing Integrins in Cancer
- (2017) Markus Nieberler et al. Cancers
- A Comprehensive Evaluation of the Activity and Selectivity Profile of Ligands for RGD-binding Integrins
- (2017) Tobias G. Kapp et al. Scientific Reports
- Cathepsin B Cleavage of vcMMAE-Based Antibody–Drug Conjugate Is Not Drug Location or Monoclonal Antibody Carrier Specific
- (2016) Benson Gikanga et al. BIOCONJUGATE CHEMISTRY
- Molecular Basis of Valine-Citrulline-PABC Linker Instability in Site-Specific ADCs and Its Mitigation by Linker Design
- (2016) M. Dorywalska et al. MOLECULAR CANCER THERAPEUTICS
- Clinical Application of Radiolabeled RGD Peptides for PET Imaging of Integrin αvβ3
- (2016) Haojun Chen et al. Theranostics
- The cryptophycins as potent payloads for antibody drug conjugates
- (2015) Vishal A. Verma et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- ?v?3 Integrin-Targeted Peptide/Peptidomimetic-Drug Conjugates: In-Depth Analysis of the Linker Technology
- (2015) Alberto Dal Corso et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Antibody–Drug Conjugates and Small Molecule–Drug Conjugates: Opportunities and Challenges for the Development of Selective Anticancer Cytotoxic Agents
- (2015) Giulio Casi et al. JOURNAL OF MEDICINAL CHEMISTRY
- Principles in the design of ligand-targeted cancer therapeutics and imaging agents
- (2015) Madduri Srinivasarao et al. NATURE REVIEWS DRUG DISCOVERY
- Antibody-Drug Conjugates: An Emerging Concept in Cancer Therapy
- (2014) Ravi V. J. Chari et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial
- (2014) Roger Stupp et al. LANCET ONCOLOGY
- Small Targeted Cytotoxics: Current State and Promises from DNA-Encoded Chemical Libraries
- (2013) Nikolaus Krall et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Conjugates of Modified Cryptophycins and RGD-Peptides Enter Target Cells by Endocytosis
- (2013) Markus Nahrwold et al. JOURNAL OF MEDICINAL CHEMISTRY
- Recent approaches for the synthesis of modified cryptophycins
- (2013) Christine Weiss et al. NATURAL PRODUCT REPORTS
- Development of a diketopiperazine-forming dipeptidyl Gly-Pro spacer for preparation of an antibody–drug conjugate
- (2013) Shino Manabe et al. MedChemComm
- RGD-Based Strategies To Target Alpha(v) Beta(3) Integrin in Cancer Therapy and Diagnosis
- (2012) Fabienne Danhier et al. MOLECULAR PHARMACEUTICS
- Approaches for the Synthesis of Functionalized Cryptophycins
- (2010) Benedikt Sammet et al. JOURNAL OF ORGANIC CHEMISTRY
- Cyclic RGD-Peptidomimetics Containing Bifunctional Diketopiperazine Scaffolds as New Potent Integrin Ligands
- (2009) Ana Sofia M. da Ressurreição et al. CHEMISTRY-A EUROPEAN JOURNAL
- Clustering and Internalization of Integrin αvβ3 With a Tetrameric RGD-synthetic Peptide
- (2009) Sancey Lucie et al. MOLECULAR THERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now